Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

After one year in Vietnam, Niklas Birkner, Head of Animal Health at Boehringer Ingelheim Vietnam, discusses the company's ...

GiveDirectly got $50 gift cards out to SNAP recipients during last month’s shutdown through a new approach to cash assistance ...

BOEHRINGER Ingelheim launched the first-ever Catvocacy Forum for the company, uniting veterinarians to elevate cat care ...

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...

However, Ringpai's IPO prospectus, citing more recent third-party market data, pegged the market at just 36.6 billion yuan ...

Maryland’s Prescription Drug Affordability Board (PDAB) serves as a bellwether for how other states may address high drug ...

This article makes a moderate such as me who voted against Trump wonder whether I can trust the Tribune newsroom.

"Watch as Trump's White House briefing takes a surprising turn at the podium, leaving viewers puzzled and intrigued. What ...